RIPK3 and cholangiocarcinoma: Interestingly, the combination of both gemcitabine or poly(I:C) and the Smac mimetic SM-164 synergistically enhanced the induction of necroptosis in CCA cells expressing RIPK1/RIPK3/MLKL when caspases were inhibited [8,46].